From: Lung clearance index in adults with non-cystic fibrosis bronchiectasis
Control subjects (n = 18) | CF patients (n = 40) | Non-CF bronchiectasis patients (n = 43) | |
---|---|---|---|
Age (years)‡‡‡‡ | 48.3 (3.9) | 28.7 (1.5)#### | 67.4 (1.1)####, ¥¥¥¥ |
Sex (% male) | 50 | 50 | 44 |
BMI (kg/m2)‡‡‡‡ | 26.8 (1.2) | 22.9 (0.5)## | 27.1 (0.7)¥¥¥¥ |
FEV1 (% pred.)‡‡‡‡ | 113.3 (4.8) | 65.9 (3.4)#### | 82.0 (3.8)####, ¥¥ |
FVC (% pred.)‡‡‡‡ | 117.2 (5.6) | 84.5 (3.0)#### | 96.1 (3.4)##, ¥ |
FEV1/FVC (%)‡‡‡‡ | 80.9 (1.0) | 65.9 (1.8)#### | 68.4 (1.7)#### |
FRCmbw (L)‡‡ | 2.52 (0.19) | 1.99 (0.09)# | 2.48 (0.10)¥¥ |
LCI‡‡‡‡ | 7.28 (0.27) | 13.17 (0.56)#### | 9.99 (0.31)##, ¥¥¥¥ |
LCIvent ‡‡‡‡ | 1.20 (0.02) | 1.65 (0.04)#### | 1.42 (0.03)###, ¥¥¥¥ |
LCIds ‡‡‡‡ | 1.13 (0.01) | 1.40 (0.03)#### | 1.27 (0.02)###, ¥¥¥¥ |
Scond (L‒1)‡‡‡‡ | 0.033 (0.007) | 0.131 (0.010)#### | 0.064 (0.007)¥¥¥¥ |
Sacin (L‒1)‡‡‡‡ | 0.118 (0.014) | 0.509 (0.056)#### | 0.373 (0.036)## |
Scond* (L‒1)‡‡‡‡ | 0.097 (0.009) | 0.308 (0.034)#### | 0.107 (0.010)¥¥¥¥ |
Sacin* (L‒1)‡‡‡‡ | 0.090 (0.012) | 0.446 (0.054)#### | 0.355 (0.037)## |